Skip to main content
Figure 2 | Genome Biology

Figure 2

From: Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors

Figure 2

Responses of hematological cell lines to kinase inhibitors. AML cells were exposed to 1 μM PI-103, 10 μM MEK-i, or 1 μM JAK-i for 72 h and viability measured by MTS and expressed as percentage to DMSO (control) treated cells. Cell lines were then ranked according to their responses to the inhibitors. Values are mean ± SD (n = 4).

Back to article page

Genome Biology

ISSN: 1474-760X

Contact us